Compounds and therapeutic applications related to inhibition of dendritic cell immunoreceptor (DCIR) activity and signaling events
US9320773B2 · kind B2 · utility
0Cited by
1References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 4, 2011 |
| Grant date | Apr 26, 2016 |
| Priority date | — |
| Expiry date | Aug 23, 2031 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is concerned with methods, compounds and pharmaceutical compositions for interfering dendritic cell immunoreceptor (DCIR) activity and signalling events. Described herein are compounds useful in targeting one or more of intracellular modulators and the uses thereof for the prevention or treatment of virus infections, and more particularly for reducing human immunodeficiency virus (HIV) binding, entry and/or replication in human cells. Exemplary compounds include peptides and antisense molecules.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.